MannKind Corporation (MNKD) Bulls Bet On a Bigger Bounce

MannKind Corporation (MNKD) is one of several pharma stocks on the move

Digital Content Group
Mar 10, 2015 at 2:27 PM
facebook twitter linkedin


It's been an eventful day for pharmaceutical stocks, with a number of names making big moves -- including MannKind Corporation (NASDAQ:MNKD). At last check, the shares were up 3.2% at $5.51. Turning to the options pits, a number of traders are wagering on additional upside for the equity.

MNKD's most active option by a mile is the in-the-money May 5 call. All signs point to buy-to-open activity, and based on the volume-weighted average price (VWAP) of $0.67, the speculators expect the stock will land above breakeven at $5.67 (strike plus VWAP) at the close on Friday, May 15 -- when the option expires.

Today's focus on calls represents a change of pace for MNKD. The equity's 50-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) put/call volume ratio of 0.67 ranks in the 76th percentile of its annual range. Similarly, MNKD's Schaeffer's put/call open interest ratio (SOIR) of 0.84 outstrips 73% of all comparable readings from the last year.

One group that's likely unhappy with MannKind Corporation's (NASDAQ:MNKD) intraday gains is short sellers. Roughly one-third of the stock's float is dedicated to short interest, representing 9.3 times the equity's daily trading volume.

 

Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!